Pfizer Inc (PFE)

1,060.00
-20.00(-1.85%)
  • Volume:
    5,248
  • Bid/Ask:
    1,050.93/1,065.00
  • Day's Range:
    1,033.73 - 1,061.17
  • Type:Equity
  • Market:Mexico
  • ISIN:US7170811035
  • S/N:717081103

PFE Overview

Prev. Close
1,080
Day's Range
1,033.73-1,061.17
Revenue
-
Open
1,060
52 wk Range
682.01-1,276.66
EPS
-
Volume
5,248
Market Cap
5.97T
Dividend (Yield)
1.60
(3.11%)
Average Volume (3m)
40,884
P/E Ratio
-
Beta
-
1-Year Change
45.21%
Shares Outstanding
5,612,866,598
Next Earnings Date
-
What is your sentiment on Pfizer Inc?
or
Market is currently closed. Voting is open during market hours.

Pfizer Inc Company Profile

Employees
78500

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Prevnar 13/Prevenar 13 (pediatric/adult), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Pfizer-BioNTech COVID-19 vaccine brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa/Staquis brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; Arvinas, Inc.; and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyNeutralSellSellStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong SellStrong SellStrong Buy
SummaryStrong BuyBuyStrong SellStrong SellStrong Buy
  • No logic for drop. This is a 60 Euro stock value
    0
    • time to jump ship. New variants are weaker, hospitalisations are down, no longer a need for vaccine or meds. vaccine centres in the UK are now practically empty. It was a good two year ride, but time to bail.
      2
      • Strong buyPresident Biden has doubled commitment of the Pfizer pill treatment to at least 20 million courses as the Covid omicron variant rages.
        0
        • Why TF is this not rising ?
          0
          • The Covid Detector device has been added to the Register of rapid tests for the detection of SARS-CoV-2 virus in Austria. This instant contactless detector from ML System
            0
            • Rumors says Albert have been arrested this Friday is it true or fraud? Anybody knows?
              7
              • cathy wood favourite...
                1
                • Not too late to get out
                  2
                  • it is going up
                    0
                    • Technical chart is bearish sorry
                      0
                  • Getting closer to low 40s
                    4
                    • 51 is the peak. You wont see it again for years
                      1
                  • can't believe I bought pfizer yesterday when everyone was in a panic selling it😅
                    1
                    • still not spike despite so many good news!
                      0
                      • PFE will touch 60 this week
                        0
                        • Will go 44€ soon
                          1
                          • Keep shorting
                            0
                            • This stock will go back to around 40 area
                              0
                          • Warren Buffet sold
                            2
                            • This is as high as PFE can go. Pandemic is a one off windfall for them and will never be replicated
                              1
                          • 55 first
                            1
                            • Next year 90
                              1
                              • people say 900 by end of next year....
                                1
                            • Hopeless
                              0
                              • Go little Pfizer, go!
                                0
                                • Yes it is good again :)
                                  0
                                  • Good time to buy. Huge earnings in store for the company.
                                    0
                                    • there is no reason to think it won't climb after next earnings report. this is a good stock due to vaccines
                                      0
                                    • 0
                                    • 0
                                  • It's too late to buy now unless you want to be a bag holder.
                                    1
                                    • Too high, i sold
                                      2
                                      • Parabolic. Correction coming soon.
                                        3
                                        • You were right
                                          0
                                      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.